Second primary malignancies in thyroid cancer patients

The late health effects associated with radioiodine ((131)I) given as treatment for thyroid cancer are difficult to assess since the number of thyroid cancer patients treated at each centre is limited. The risk of second primary malignancies (SPMs) was evaluated in a European cohort of thyroid cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubino, C, de Vathaire, F, Dottorini, M E, Hall, P, Schvartz, C, Couette, J E, Dondon, M G, Abbas, M T, Langlois, C, Schlumberger, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394426/
https://www.ncbi.nlm.nih.gov/pubmed/14583762
http://dx.doi.org/10.1038/sj.bjc.6601319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394426/
https://www.ncbi.nlm.nih.gov/pubmed/14583762
http://dx.doi.org/10.1038/sj.bjc.6601319

Ejemplares similares